• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » ICMRA Pledges to Support Global Pharmaceutical Efforts in Fighting COVID-19

ICMRA Pledges to Support Global Pharmaceutical Efforts in Fighting COVID-19

May 4, 2020

The International Coalition of Medicines Regulatory Authorities (ICMRA) has released new recommendations to ensure efficient regulatory processes that will support the development of diagnostics and treatments for COVID-19.

Stemming from three virtual meetings with more than 100 participants, the ICMRA emphasizes the need for well-designed and large randomized controlled trials that will investigate the safety and efficacy of potential therapies for the virus.

In its statement, the ICMRA suggests that data from real-world evidence and observational studies may be necessary to complement the evidence gleaned from these randomized clinical trials. The ICMRA also wrote that it will work with pharmaceutical companies, distributors and manufacturers to help address drug supply issues and shortages during the pandemic.

The ICMRA also recognized in its recommendations the importance of addressing the COVID-19 crisis in low- and middle-income countries and populations, considering their higher risk for morbidity and mortality associated with COVID-19. The ICMRA recommends that access to medicines and medical devices, including vaccines once they become available, be ensured for these populations.

COVID-19
    • Related Directories

      Olumiant (baricitinib)

      Veklury (remdesivir)

      Comirnaty (COVID-19 Vaccine, mRNA)

    Upcoming Events

    • 05Dec

      Thriving in Clinical Research – Overcoming Common Challenges as a Site: Part 3 – Site Resourcing

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing